]>
IRCT20220703055361N1 IRCT 2023-02-19 Esfahan University of Medical Sciences Effect of Different dialysates on serum potassium Comparison of the effect of dialysates with 2meq/l and 3meq/l potassium as a result of adding KCl onserum potassium levels of patients before and after hemodialysis in hemodialysis patients 2022-08-23 anticipated 160 Complete https://irct.ir/trial/64686 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: For this purpose, we will use the block randomization method. For this purpose, the website https://www.sealedenvelope.com/ will be used. 40 blocks of 4 will be created by the site, which will assign 2 people to the Case group and 2 people to the Control group in each block. N/A hyperkalemia in hemodialysis patients. Intervention 1: Intervention group: Dialysis with 2 meq/l potassium dialysate to which 17.5 cc ampoules of 15% potassium chloride have been added per liter of concentrated dialysis solution (equivalent to 3 meq/l solution). Intervention 2: Control group: Dialysis with 2 meq/l potassium dialysate. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is there is no more information
public Mehran Haddadi
Arjan apartment, kouchmeshki st, fatemieh blvd,
Hamadan Iran (Islamic Republic of) 6515913463 +98 81 3821 7276 Haddadi.mehran@gmail.com Esfahan University of Medical Sciences scientific Mehran Haddadi
No. 1,Arjan apartment, koochmeshki Ave., Fatemieh Blvd., hamedan Town
hamedan Iran (Islamic Republic of) 6515913463 +98 81 3821 7276 haddadi.mehran@gmail.com Esfahan University of Medical Sciences Iran (Islamic Republic of) hemodialysis for more than 3 months stable physical and labaratory condition regular treatment program (3 times dialysis per week) stable vascular access stable blood pressure stable hemodynamic and cardiovascular condition serum potassium less than or equal to 4.5 The patient should be hospitalized. (for the convenience of measuring potassium 6 hours after the end of dialysis) 20 years 75 years Both need a blood transfusion for any reason N18.5 Chronic kidney disease, stage 5 Treatment - Other Treatment - Other Intervention group: Dialysis with 2 meq/l potassium dialysate to which 17.5 cc ampoules of 15% potassium chloride have been added per liter of concentrated dialysis solution (equivalent to 3 meq/l solution) Control group: Dialysis with 2 meq/l potassium dialysate Serum potassium level. Timepoint: Measurement of serum potassium in patients before dialysis, immediately after dialysis, 6 hours after dialysis. Method of measurement: Serum potassium measurement of patients in the laboratory by electrode method and using EasyLyte REF 2124 device. Dialysate potassium level. Timepoint: Measurement of potassium level of dialysate during dialysis from afferent and efferent coupling. Method of measurement: dialysate potassium measurement in the laboratory by electrode method and using EasyLyte REF 2124 device. Esfahan University of Medical Sciences Approved 2022-04-20 Research Ethics Committees of Research Ethics Committee of the "Alzahra Research Centers" Address: Hazar Jarib St., Isfahan University of Medical Sciences and Health Care Services, Building No. 4 - University Research and Technology Vice-Chancellor اصفهان Isfehan Iran (Islamic Republic of)